Nov. 13, 2013
/PRNewswire/ -- IGI Laboratories, Inc. (NYSE Amex: IG), a
based generic topical pharmaceutical company will be presenting at the Oppenheimer 24
Annual Healthcare Conference. The Conference will take place on
December 10 - 11, 2013
at the Crowne Plaza Hotel in
New York, New York
, President and CEO and
, Chief Financial Officer of IGI Laboratories, Inc. will present on
Tuesday December 10, 2013
4:30 PM ET
. Investors attending the conferences who wish to meet with Mr. Grenfell-Gardner and Mrs. Collins for a one-on-one meeting should contact their Oppenheimer representative or the Company.
The replay of the presentation will be webcast and will be available for 90 days online on the Investors section of the Company's website at
About IGI Laboratories, Inc.
IGI Laboratories is a generic topical pharmaceutical company. We develop and manufacture topical formulations for the pharmaceutical, OTC, and cosmetic markets. Our mission is to be a leader in the generic topical prescription drug market.
SOURCE IGI Laboratories, Inc.